PROGNOSTIC FACTORS IN PATIENTS WITH SURGICAL RESECTION OF PANCREATIC NEUROENDOCRINE TUMOURS

被引:7
作者
Dima, S. O. [1 ,2 ]
Dumitrascu, T. [1 ]
Pechianu, C. [2 ,3 ]
Grigorie, R. T. [1 ]
Brasoveanu, V. [1 ]
Sorop, A. [2 ]
Lupescu, I. [4 ]
Purnichescu-Purtan, R. [5 ]
Croitoru, A. [1 ,6 ]
Bacalbasa, N. [1 ,2 ]
Tanase, A. [6 ]
Tomescu, D. R. [1 ]
Herlea, V. [3 ,6 ]
Popescu, I. [1 ,6 ]
机构
[1] Fundeni Clin Inst, Ctr Digest Dis & Liver Transplantat, Bucharest, Romania
[2] Fundeni Clin Inst, Ctr Excellence Translat Med, Bucharest, Romania
[3] Fundeni Clin Inst, Dept Pathol, Bucharest, Romania
[4] Fundeni Clin Inst, Dept Radiol & Med Imaging, Bucharest, Romania
[5] Univ Politehn Bucuresti, Dept Math Methods & Models, Bucharest, Romania
[6] Titu Maiorescu Univ, Acad Nicolae Cajal Inst Med Sci Res, Bucharest, Romania
关键词
pancreatic; neuroendocrine; surgery; prognostic factors; LONG-TERM SURVIVAL; CLASSIFICATION-SYSTEM; ENDOCRINE NEOPLASMS; SURGERY; PNETS; STRATEGIES; RECURRENCE; RELEVANCE; PROPOSAL;
D O I
10.4183/aeb.2018.389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context. Pancreatic neuroendocrine tumours (PanNETs) are rare pancreatic neoplasms. PanNETs can be treated by multimodal approach including surgery, locoregional and systemic therapy. Objective. The aim of the present study is to evaluate predictive factors of overall survival in patients with PanNETs surgically treated at a single center. Subjects and methods. The study group consisted of 120 patients with PanNETs who had undergone surgery at the Center of Digestive Diseases and Liver Transplantation of Fundeni Clinical Institute, Bucharest, Romania. Surgical resection of the primary tumor was performed in 110 patients. Results. Tumor size > 2 cm (p=0.048) (90% CI) lymph node involvement (p=0.048), ENET grade (p<0.001), distant metastases (p<0.001), Ki 67 index (<2%, 2-5%, 5-10%, 10-20%, >20%) (p<0.001) were identified as significant prognostic factors for OS on univariate analysis. Using multivariate Cox proportional regression model we found that distant metastases and Ki 67 index were independent risk factors for the survival outcome. Conclusions. Surgery with curative intent should be considered in all cases if clinically appropriate and technically feasible. High grade (Ki67 index >= 10%) tumours were associated with a 2- fold increase in risk of death as compared to those with a Ki67 <10%.
引用
收藏
页码:389 / 393
页数:5
相关论文
共 35 条
[1]   Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours [J].
Bettini, R. ;
Boninsegna, L. ;
Mantovani, W. ;
Capelli, P. ;
Bassi, C. ;
Pederzoli, P. ;
Delle Fave, G. F. ;
Panzuto, F. ;
Scarpa, A. ;
Falconi, M. .
ANNALS OF ONCOLOGY, 2008, 19 (05) :903-908
[2]   Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors - Analysis of 3851 patients [J].
Bilimoria, Karl Y. ;
Talamonti, Mark S. ;
Tomlinson, James S. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Ko, Clifford Y. ;
Bentrem, David J. .
ANNALS OF SURGERY, 2008, 247 (03) :490-500
[3]  
Bosman FT, 2010, WHO Classification of tumors of the digestive system, V4th
[4]   Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas [J].
Chu, QD ;
Hill, HC ;
Douglass, HO ;
Driscoll, D ;
Smith, JL ;
Nava, HR ;
Gibbs, JF .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (09) :855-862
[5]   Necrosis and Angioinvasion Predict Adverse Outcome in Pancreatic Neuroendocrine Tumors After Curative Surgical Resection: Results of a Single-Center Series [J].
Demir, Resit ;
Pohl, Johann ;
Agaimy, Abbas ;
Peros, Georgios ;
Perrakis, Aristoteles ;
Merkel, Susanne ;
Hohenberger, Werner ;
Klein, Peter .
WORLD JOURNAL OF SURGERY, 2011, 35 (12) :2764-2772
[6]   Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors [J].
Deshpande, V ;
Fernandez-del Castillo, C ;
Muzikansky, A ;
Deshpande, A ;
Zukerberg, L ;
Warshaw, AL ;
Lauwers, GY .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (09) :1145-1153
[7]   Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors [J].
Dralle, H ;
Krohn, SL ;
Karges, W ;
Boehm, BO ;
Brauckhoff, M ;
Gimm, O .
WORLD JOURNAL OF SURGERY, 2004, 28 (12) :1248-1260
[8]   Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution [J].
Ekeblad, Sara ;
Skogseid, Britt ;
Dunder, Kristina ;
Oberg, Kjell ;
Eriksson, Barbro .
CLINICAL CANCER RESEARCH, 2008, 14 (23) :7798-7803
[9]   Determining prognosis in patients with pancreatic endocrine neoplasms: Can the WHO classification system be simplified? [J].
Ferrone, Cristina R. ;
Tang, Laura H. ;
Tomlinson, James ;
Gonen, Mithat ;
Hochwald, Steven N. ;
Brennan, Murray F. ;
Klimstra, David S. ;
Allen, Peter J. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (35) :5609-5615
[10]   Differences in survival by histologic type of pancreatic cancer [J].
Fesinmeyer, MD ;
Austin, MA ;
Li, CI ;
De Roos, AJ ;
Bowen, DJ .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (07) :1766-1773